Abstract
This is a protocol for a Cochrane Review (Diagnostic test accuracy). The objectives are as follows:
Primary objectives
To determine the diagnostic accuracy of Xpert MTB/RIF and Xpert Ultra for a) PTB in children presumed to have tuberculosis; b) lymph node tuberculosis in children presumed to have tuberculosis; c) tuberculous meningitis in children presumed to have tuberculosis; and d) rifampicin resistance in children presumed to have tuberculosis.
For tuberculosis detection, the role of the index tests would be a replacement for standard practice.
For rifampicin resistance detection, the role of the index tests would be an initial replacement test for culture‐based drug susceptibility testing.
| Original language | English |
|---|---|
| Article number | CD013359 |
| Pages (from-to) | CD013359 |
| Journal | Cochrane Database of Systematic Reviews |
| Volume | 2019 |
| Issue number | 6 |
| Early online date | 17 Jun 2019 |
| DOIs | |
| Publication status | Published - 17 Jun 2019 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver